Home  »  News   »  Theravance Biopharma Inc. (TBPH) market price of $...

Theravance Biopharma Inc. (TBPH) market price of $10.27 offers the impression of an exciting value play

For the readers interested in the stock health of Theravance Biopharma Inc. (TBPH). It is currently valued at $10.27. When the transactions were called off in the previous session, Stock hit the highs of $10.465, after setting-off with the price of $10.31. Company’s stock value dipped to $10.17 during the trading on the day. When the trading was stopped its value was $10.61.Recently in News on November 22, 2022, Theravance Biopharma, Inc. Announces Final Results of Tender Offer. Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced the final results of its Dutch auction tender offer (the “Offer”) to purchase up to $95 million of its ordinary shares, par value $0.00001 per share (the “Shares”), which expired at midnight, New York City time, at the end of the day on November 17, 2022. You can read further details here

Theravance Biopharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $13.17 on 01/10/22, with the lowest value was $7.53 for the same time period, recorded on 07/14/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Theravance Biopharma Inc. (TBPH) full year performance was 21.54%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Theravance Biopharma Inc. shares are logging -22.02% during the 52-week period from high price, and 36.39% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.53 and $13.17.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 939587 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Theravance Biopharma Inc. (TBPH) recorded performance in the market was -7.06%, having the revenues showcasing 10.19% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 723.11M, as it employees total of 158 workers.

Analysts verdict on Theravance Biopharma Inc. (TBPH)

During the last month, 2 analysts gave the Theravance Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 9.70, with a change in the price was noted +0.65. In a similar fashion, Theravance Biopharma Inc. posted a movement of +6.76% for the period of last 100 days, recording 954,418 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TBPH is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Theravance Biopharma Inc. (TBPH): Technical Analysis

Raw Stochastic average of Theravance Biopharma Inc. in the period of last 50 days is set at 38.34%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 28.93%. In the last 20 days, the company’s Stochastic %K was 35.92% and its Stochastic %D was recorded 45.57%.

Let’s take a glance in the erstwhile performances of Theravance Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -7.06%. Additionally, trading for the stock in the period of the last six months notably improved by 14.37%, alongside a boost of 21.54% for the period of the last 12 months. The shares increased approximately by -8.47% in the 7-day charts and went down by 3.32% in the period of the last 30 days. Common stock shares were driven by 10.19% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]